Ani Pharmaceuticals, Inc. (NASDAQ:ANIP)

CAPS Rating: 2 out of 5

A biopharmaceutical company that licenses and develops hormone therapy products to treat men and women.


Player Avatar RXDOC73 (99.36) Submitted: 12/14/2011 1:36:14 PM : Outperform Start Price: $91.08 ANIP Score: -89.65

Takeover target

Member Avatar Rajhi (61.35) Submitted: 12/14/2011 5:45:43 PM
Recs: 0

You mean Future busted biotech. Cop.
I believe that is threeimposslble drugs
to make Women vigra,losing can't
Beat major drugs corps.

Featured Broker Partners